Sol-Gel Technologies Ltd

NASDAQ:SLGL  
7.50
-0.12 (-1.51%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)169.18M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$17.65 Million
Adjusted EPS$0.40
See more estimates
10-Day MA$7.79
50-Day MA$8.92
200-Day MA$10.54
See more pivots

Sol-Gel Technologies Ltd Stock, NASDAQ:SLGL

Weizmann Science Park, 7 Golda Meir Street, Ness Ziona, Tel Aviv 74036
Israel
Phone: +972.8.931.3433
Number of Employees: 65

Description

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.